A Study to Evaluate the Safety and Efficacy of AHB-137 in Healthy Participants and HBeAg-negative Chronic Hepatitis B (CHB) Patients

NCT06115993 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatitis B, Chronic

Interventions

DRUG: AHB-137 injection
DRUG: Placebo

Sponsor

Ausper Biopharma Co., Ltd.